Toho Holdings Co., Ltd. (TYO:8129)
4,562.00
-25.00 (-0.55%)
At close: Dec 5, 2025
Toho Holdings Revenue
Toho Holdings had revenue of 392.09B JPY in the quarter ending September 30, 2025, with 2.66% growth. This brings the company's revenue in the last twelve months to 1.53T, up 2.31% year-over-year. In the fiscal year ending March 31, 2025, Toho Holdings had annual revenue of 1.52T with 2.83% growth.
Revenue (ttm)
1,531.42B
Revenue Growth
+2.31%
P/S Ratio
0.19
Revenue / Employee
201.26M
Employees
7,609
Market Cap
295.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1,518.50B | 41.78B | 2.83% |
| Mar 31, 2024 | 1,476.71B | 88.15B | 6.35% |
| Mar 31, 2023 | 1,388.57B | 122.39B | 9.67% |
| Mar 31, 2022 | 1,266.17B | 55.90B | 4.62% |
| Mar 31, 2021 | 1,210.27B | -53.43B | -4.23% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,213.71B |
| HOYA Corporation | 892.50B |
| Takeda Pharmaceutical Company | 4,417.00B |
| Daiichi Sankyo Company | 1,978.88B |
| Otsuka Holdings | 2,418.53B |
| Astellas Pharma | 2,006.82B |
| Terumo | 1,062.42B |
| Shionogi & | 437.26B |